156 related articles for article (PubMed ID: 2840551)
21. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.
Hammerschmidt W; Sugden B
Cell; 1988 Nov; 55(3):427-33. PubMed ID: 2846181
[TBL] [Abstract][Full Text] [Related]
22. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
Kirchmaier AL; Sugden B
J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
[TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
Gahn TA; Schildkraut CL
Cell; 1989 Aug; 58(3):527-35. PubMed ID: 2547525
[TBL] [Abstract][Full Text] [Related]
24. Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function.
Pesano RL; Pagano JS
J Virol; 1986 Dec; 60(3):1159-62. PubMed ID: 3023667
[TBL] [Abstract][Full Text] [Related]
25. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
Reisman D; Sugden B
Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
[TBL] [Abstract][Full Text] [Related]
26. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
Kirchmaier AL; Sugden B
J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
[TBL] [Abstract][Full Text] [Related]
27. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
Orlowski R; Miller G
J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
[TBL] [Abstract][Full Text] [Related]
28. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
Leight ER; Sugden B
Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
[TBL] [Abstract][Full Text] [Related]
29. Transforming functions associated with Epstein-Barr virus.
Sugden B; Yates J; Mark W
J Invest Dermatol; 1984 Jul; 83(1 Suppl):82s-87s. PubMed ID: 6330229
[TBL] [Abstract][Full Text] [Related]
30. Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture.
Mecsas J; Sugden B
Annu Rev Cell Biol; 1987; 3():87-108. PubMed ID: 2825737
[TBL] [Abstract][Full Text] [Related]
31. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
Reisman D; Yates J; Sugden B
Mol Cell Biol; 1985 Aug; 5(8):1822-32. PubMed ID: 3018528
[TBL] [Abstract][Full Text] [Related]
32. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
Wysokenski DA; Yates JL
J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
[TBL] [Abstract][Full Text] [Related]
33. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
Takada K; Ji Z; Fujiwara S; Shimizu N; Tanabe-Tochikura A
J Virol; 1992 Sep; 66(9):5590-3. PubMed ID: 1323712
[TBL] [Abstract][Full Text] [Related]
34. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
Yates JL; Warren N; Sugden B
Nature; 1985 Feb 28-Mar 6; 313(6005):812-5. PubMed ID: 2983224
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.
Yates JL; Guan N
J Virol; 1991 Jan; 65(1):483-8. PubMed ID: 1845903
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus episome stability is coupled to a delay in replication timing.
Zhou J; Snyder AR; Lieberman PM
J Virol; 2009 Mar; 83(5):2154-62. PubMed ID: 19073720
[TBL] [Abstract][Full Text] [Related]
37. Episomal replication timing of gamma-herpesviruses in latently infected cells.
Vogel B; Full F; Biesinger B; Linden C; Alberter B; Ensser A
Virology; 2010 May; 400(2):207-14. PubMed ID: 20172574
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2.
Zhou J; Deng Z; Norseen J; Lieberman PM
J Virol; 2010 May; 84(10):4979-87. PubMed ID: 20200249
[TBL] [Abstract][Full Text] [Related]
39. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.
Sugden B; Marsh K; Yates J
Mol Cell Biol; 1985 Feb; 5(2):410-3. PubMed ID: 2983194
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectors.
Kenney S; Ge JQ; Westphal EM; Olsen J
Hum Gene Ther; 1998 May; 9(8):1131-41. PubMed ID: 9625252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
